Gauntlet™ Disinfection System Beta-Site Program Announced

“Our goal with Gauntlet is to provide medical treatment facilities with the capability to treat bloodborne pathogens found in infectious fluid surgical waste streams for safe ‘down the drain’ disposal, while enhancing employee safety and reducing disposal costs.”

Destroying infectious fluid surgical wastes for safe "down the drain" disposal

For Immediate Release

Release Date:
Friday, October 17, 2014

Knoxville, TN – In anticipation of the targeted 2016 commercial launch of the Gauntlet™ Disinfection System Innovasan has announced the establishment of a Beta-Site Development Program. Innovasan is looking for interested medical treatment facilities to participate in a Gauntlet™ product field trial. The field trial is designed as an outreach to bring the voice of the customer into the final stage of product development prior to a nationwide launch.

Medical treatment facility generators of infectious fluid medical waste, which may contain Methicillin-resistant Staphylococcus aureus (MRSA), hepatitis C (HCV), and Ebola virus, among others, are being challenged by an urgent and escalating need to enhance patient and employee safety while at the same time address the growing awareness that the disposal of untreated, infectious fluid wastes into sanitary sewer systems and landfills poses an emerging threat to our communities and the environment. While “down the drain” remains one of the most cost effective disposal methods available today the discharge of untreated fluid medical waste streams into our sanitary sewer systems places an additional public health burden on our sewage treatment plants and increases the risk of spreading infectious diseases into the environment.

“There is a clear need for hospitals, surgery centers and other medical treatment facilities to be able to destroy these infectious fluid medical waste streams prior to disposal. Our goal with Gauntlet™ is to provide medical treatment facilities with the capability to treat bloodborne pathogens found in infectious fluid surgical waste streams for safe ‘down the drain’ disposal, while enhancing employee safety and reducing disposal costs.” said Jeff Hubrig, Jr., Manager of Business Development.

The Beta-Site Development Program is an invitation for medical treatment facilities committed to clean technology and environmental sustainability to trial the Gauntlet™ Disinfection System. We believe that field testing is essential to documenting product performance, user satisfaction and regulatory compliance and to ensuring a successful launch.

If you would like to participate in a Gauntlet™ Disinfection System field trial or would like more information about our Beta-Site Development Program please contact Jeff Hubrig Jr. at (865)470-4900.